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MKLP2, a kinesin-6, has critical roles during the metaphase-anaphase transition and cytokinesis. Its motor domain contains conserved nucleotide
binding motifs, but is divergent in sequence (~35% identity) and size (~40% larger) compared to other kinesins. Using cryo-electron
microscopy and biophysical assays, we have undertaken a mechanochemical dissection of the microtubule-bound MKLP2 motor domain during
its ATPase cycle, and show that many facets of its mechanism are distinct from other kinesins. While the MKLP2 neck-linker is directed towards
the microtubule plus-end in an ATP-like state, it does not fully dock along the motor domain. Furthermore, the footprint of the MKLP2 motor
domain on the MT surface is altered compared to motile kinesins, and enhanced by kinesin-6-specific sequences. The conformation of the
highly extended loop6 insertion characteristic of kinesin-6s is nucleotide-independent and does not contact the MT surface. Our results
emphasize the role of family-specific insertions in modulating kinesin motor function.
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ABSTRACT 40 
 41 
MKLP2, a kinesin-6, has critical roles during the metaphase-anaphase transition and 42 
cytokinesis. Its motor domain contains conserved nucleotide binding motifs, but is 43 
divergent in sequence (~35% identity) and size (~40% larger) compared to other 44 
kinesins. Using cryo-electron microscopy and biophysical assays, we have 45 
undertaken a mechanochemical dissection of the microtubule-bound MKLP2 motor 46 
domain during its ATPase cycle, and show that many facets of its mechanism are 47 
distinct from other kinesins. While the MKLP2 neck-linker is directed towards the 48 
microtubule plus-end in an ATP-like state, it does not fully dock along the motor 49 
domain. Furthermore, the footprint of the MKLP2 motor domain on the MT surface is 50 
altered compared to motile kinesins, and enhanced by kinesin-6-specific sequences. 51 
The conformation of the highly extended loop6 insertion characteristic of kinesin-6s is 52 
nucleotide-independent and does not contact the MT surface. Our results emphasize 53 
the role of family-specific insertions in modulating kinesin motor function. 54 
 55 
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INTRODUCTION 65 
 66 
The success of mitosis depends on the intricate timing, precise localisation and 67 
regulated interactions between multiple spindle components. MKLP2 (Kif20A), a 68 
kinesin-6 family motor, is involved at several key stages of cell division, and in 69 
particular is essential for cytokinesis in mammals (1). MKLP2 interacts with and is 70 
regulated by a number of mitotic kinases including Cdk1/cyclin B prior to anaphase 71 
onset (2, 3). MKLP2 is required for localisation of Chromosome Passenger Complex 72 
(CPC) components, including Aurora B kinase, to the midzone at anaphase (4), 73 
which is in turn required for Kif4A and PRC1 function (5). MKLP2 also participates in 74 
myosin II recruitment for cleavage furrow ingression (6) and interacts with the cell 75 
membrane to promote abscission (7). In addition, it is a substrate for polo-like kinase 76 
1 (Plk1), and the co-association at the midzone of MKLP2 and Plk1 is also required 77 
for cytokinesis (8). In the light of these activities and because MKLP2 is found to be 78 
highly expressed in tumour tissue (9), inhibition of MKLP2 by antimitotics has been 79 
explored, and small molecule inhibitors of MKLP2 have been shown to perturb 80 
mammalian cytokinesis (10, 11). While there has been significant focus on dissecting 81 
cell cycle dependent function and regulation of MKLP2, little is known about the 82 
molecular mechanisms that drive this function. MKLP2 shares only approximately 83 
35% sequence identity with kinesin-1 (Kin1), which suggests that much of what is 84 
known about kinesin molecular function may not necessarily apply to this motor (12).  85 
 86 
Little is known about the molecular and mechanistic properties of MKLP2. A related 87 
kinesin family member, the kinesin-6 MKLP1 - part of the centralspindlin complex 88 
that is also essential for cytokinesis - is a plus-end directed motor (13), as is Kif20B, 89 
another kinesin-6 (14). The centralspindlin holocomplex has anti-parallel microtubule 90 
(MT) bundling capability (15) consistent with its localisation and function in the 91 
spindle midzone. Functional diversification within the kinesin superfamily is derived in 92 
part from variation within kinesin motor domain itself. Kinesin-6s are particularly 93 
intriguing in this context because they are up to ~40% larger than the canonical Kin1 94 
motor domain (Fig 1A) due to a number of unique loop insertions. Within the 95 
mammalian MKLP2 motor domain sequence, these unique features include a ~60 96 
residue N-terminal extension, insertions in loop 2 (18 aa), loop 6 (99 aa), loop 8 (5 97 
aa) and loop 12 (6 aa), along with an extended non-canonical neck-linker; there is 98 
also a ~40 aa insert between this neck linker region and MKLP2’s coiled coil. 99 
However, the effects of these modifications on motor structure and function are 100 
unknown.   101 
 102 
Visualisation of the kinesin-MT interaction and its sensitivity to nucleotide provides a 103 
structural framework for understanding motor functional output. Cryo-EM is an 104 
essential structural method for characterising kinesin-MT complexes and has, to 105 
date, revealed a mechanistic consensus for plus-end directed kinesins (16–18). To 106 
address the deficit in molecular understanding of the MKLP2 mechanism, we have 107 
determined cryo-EM reconstructions and calculated atomic models of MT-bound 108 
MKLP2 in different nucleotide states. These structures provide a visualisation of the 109 
conformations that functional MKLP2 undergoes, and which are blocked by small 110 
molecule inhibitors (10, 11). These structures, supported by biochemical and 111 
biophysical characterisations, reveal many atypical properties and behaviours of the 112 
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MKLP2 motor domain. Strikingly, these noncanonical properties are superimposed 113 
on a more generally conserved ATP-dependent subdomain movements within the 114 
motor domain. MKLP2 motor domain binding on the MT surface is shifted compared 115 
with other kinesins, and additional contacts between the MT and MKLP2 insertions in 116 
loops 2, 8 and 12 are formed. Additionally, while the MKLP2 neck-linker is directed 117 
towards the MT plus end in an ATP-like state enabling formation of the cover-neck 118 
bundle, the neck-linker does not fully dock against the motor core and exhibits more 119 
flexibility than is seen in transport motors such as Kin1 and kinesin-3 (Kin3). 120 
Moreover, the characteristic kinesin-6 large insertion in loop6 forms a discrete 121 
additional subdomain protruding from the MKLP2 motor core and away from the MT. 122 
Our characterisation provides a context in which the functional contribution of this 123 
motor in mitosis can be evaluated and offers a mechanistic framework in which other 124 
atypical members of the kinesin superfamily can be considered. 125 
 126 
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RESULTS 130 
 131 
The biochemical properties of the MKLP2 motor domain differ from those of other 132 
kinesins 133 
We expressed monomeric mammalian MKLP2 motor domain constructs 1-520 and 134 
25-520 and measured their steady-state MT-stimulated ATPase activity (Fig 1B). Fits 135 
of the data to a Michaelis Menten function reveal values of kcat = 4.34±0.14 s
-1 and 136 
K0.5,MT = 0.93±0.12M for 1-520 and kcat = 4.38±0.20 s
-1 and K0.5,MT = 1.07±0.18M for 137 
25-520, showing that the presence or absence of the extended MKLP2 N-terminus 138 
does not affect steady state ATPase parameters. MT binding stimulates kcat >1000-139 
fold (19–21) to levels similar to the mitotic kinesin-5 (Kin5) and about 10-fold slower 140 
than the transport kinesins Kin1 or Kin3 (22) (Table 1). Since the residues 1-25 are 141 
intrinsically disordered we used the 25-520 construct - which has a better yield during 142 
recombinant protein expression - for all subsequent assays. We refer to this 25-520 143 
construct as MKLP2-MD. 144 
 145 
To further dissect the MKLP2-MD ATPase cycle and its dependence on MTs, the 146 
dynamic interaction between MKLP2-MD and either 2’deoxy 3’mant ATP (2’dmT) or 147 
2’deoxy 3’mant ADP (2’dmD) in the presence and absence of MT was measured (Fig 148 
1C,D). In each case, the nucleotide binding transients consisted of fast and slow 149 
phases. The faster phase varies linearly with [nucleotide], implying that this is a 150 
readout of the initial binding of nucleotide to the active site; the slower phase shows 151 
little dependence on [nucleotide], implying that it measures a subsequent 152 
isomerization step. For 2’dmT (Fig 1C), rates in the presence and absence of MT are 153 
nearly identical (including Y intercept), implying that – unlike e.g. Kin-1 or Kin-5 – the 154 
kinetics of binding 2’dmT to MKLP2-MD are essentially independent of MTs. Binding 155 
of 2’dmD produces similar behaviour (Fig 1D), with an approximately two-fold 156 
increase in the apparent second order rate constant for 2’dmD binding. Extrapolation 157 
of the linear fit to the origin defines an apparent 2’dmD dissociation rate constant, 158 
and in other kinesins, such plots typically go through the origin in the absence of 159 
MTs, implying tight ADP binding within the error of the measurement (20-23). 160 
However, as is evident from Fig 1D, the corresponding plot for MKLP2-MD intercepts 161 
the y axis well above the origin. Although this is an indirect way of calculating the 162 
ADP dissociation rate constant, it implies that the interaction of ADP with MKLP2 is 163 
unlike that of other kinesins. In order to directly examine the kinetics of ADP release 164 
from MKLP2-MD in the absence of MTs, we formed a complex of MKLP2-MD:2’dmD 165 
and mixed it in the stopped flow with a large excess of unlabelled ADP. Figure1-166 
figure suplement1 shows that the resulting fluorescence decrease, which reflects 167 
2’dmD dissociation, fits a single exponential process with rate constant of 51.9 ± 0.1 168 
sec-1, i.e. the rate of ADP release from MKLP2-MD in the absence of MTs is 169 
unusually high. and a two-fold decrease in the apparent dissociation rate constant in 170 
the presence of MTs. Taken together, these data suggest that there is a relative 171 
uncoupling of allosteric communication between the MT binding and catalytic sites in 172 
MKLP2-MD compared to other kinesins that have been described (22, 23).   173 
 174 
The binding affinity of MKLP2-MD to MTs was measured as a function of nucleotide 175 
state by a co-sedimentation assay, using a fixed [MKLP2-MD] and a range of [MT]. 176 
Plots of fraction of bound MKLP2-MD versus [MT] are depicted in Fig 1E. These 177 
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were fit to a quadratic function assuming a 1:1 motor:tubulin dimer stoichiometry to 178 
yield apparent dissociation constants (Fig 1E; Table 1). Like other kinesin family 179 
members (Table 1)(16, 22, 24–27), MT affinity of MKLP2-MD is modulated by the 180 
state of the catalytic site, with binding in the absence of nucleotide (NN) or presence 181 
of AMPPNP demonstrating a higher affinity than that with ADP or ADP.AlFx (Table 182 
1). In marked contrast to other kinesins, however, the ADP state of MKLP2-MD - 183 
which usually represents the kinesin weak binding state (24, 26, 28) – demonstrates 184 
a relatively high affinity. ThusHowever, the difference in affinity between nucleotide 185 
states that in other kinesins are “strong” binding (NN, AMPPNP) and “weak” binding 186 
(ADP) is only about 8.5-fold.  By contrast, the corresponding difference for Kin1 is 187 
20-50-fold (Table 1)(16, 22, 24–27).  Furthermore, while the ATP transition analogue 188 
ADP.AlFx produces a strong binding state in Kin1, it maintains MKLP2 in a weaker 189 
binding state (Table 1). This smaller difference in apparent affinities of MKLP2 in 190 
different states appears to reflect an increased affinity of the MD in “weak” binding 191 
states compared to other kinesins (24, 26, 28). ThusOverall, the motorMKLP2-MD 192 
associates with MTs relatively strongly throughout its ATPase cycle. Together, these 193 
results provide additional evidence of the non-canonical properties of the MKLP2-MD 194 
mechanism.   195 
 196 
Conserved nucleotide-dependent subdomain rearrangements provides a structural 197 
framework for MKLP2 divergence 198 
To visualise the MKLP2-MD (Fig 2A) and provide insight into these unusual 199 
biochemical properties, we calculated MT-bound MKLP2-MD reconstructions with 200 
different nucleotides bound: 1) ADP; 2) no nucleotide (NN) using apyrase treatment; 201 
3, 4) ATP-like analogues (AMPPNP and ADP.AlFx) (Fig2-figure supplement 1). Our 202 
ability to determine an ADP-bound structure highlights the tighter association of this 203 
motor with MTs throughout its ATPase cycle and is consistent with the biochemical 204 
data (Fig 1E). The asymmetric unit of all these reconstructions is the MKLP2 motor 205 
domain bound to an αβ-tubulin dimer within the MT (Fig 2B), , which shows a 206 
resolution gradient between the MT and bound MKLP2 (Fig2–figure supplement 1; 207 
Fig2–figure supplement 2); for interpretation of MKLP2-MD mechanochemistry, 208 
reconstructions were filtered according to the local resolution of the motor domain. 209 
To facilitate interpretation of the cryo-EM density, we calculated comparative models 210 
for each nucleotide state and docked them into the density using flexible fitting (Table 211 
2, Fig2-figure supplement 32, Fig2-figure supplement 43). In addition, multiple loop 212 
conformations were generated and clustered to represent loops with ambiguous fit. 213 
This yielded a set of models (Table 2; Fig2-figure supplement 43) that show 214 
nucleotide-dependent conformational changes of MT-bound MKLP2 including the 215 
conformation and variation of the MKLP2-specific inserts (Fig 2A). 216 
 217 
These structures show that the overall organisation of MKLP2-MD is similar 218 
compared to other kinesins, with the major contact site between motor and MT being 219 
centred over the tubulin intradimer interface (Fig 2B). The coordinated 220 
conformational changes that occur in Kin1 in response to MT and nucleotide binding 221 
have been described in terms of three independently articulated subdomains that 222 
move with respect to each other during the MT-bound ATPase cycle (17, 29): the 223 
tubulin-binding subdomain, the Switch I/II subdomain and the P-loop subdomain (Fig 224 
2C). This structural simplification is useful in describing global rearrangements in the 225 
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motor domain. Our reconstructions demonstrate that the overall features of 226 
nucleotide-dependent subdomain movement described for Kin1 also apply to MKLP2 227 
(Fig2D; Movie 1), albeit the comparison is incomplete given the lack of a tubulin/MT-228 
bound Kin1 ADP structure. In the transition from ADP-bound to NN structures 229 
(Fig2D, left to middle), the MKLP2 Switch I/II and P-loop subdomains both rotate 230 
away from each other slightly and relative to the static tubulin-binding domain. In the 231 
transition from the NN to ADP.AlFx conformations (Fig2D, middle to right), both 232 
domains rotate towards the catalytic site, with the rotation of the P-loop subdomain 233 
being greater than the Switch I/II subdomain. This supports the idea that these 234 
subdomain movements are a conserved facet of kinesin mechanochemistry even 235 
amongst motors with highly distinct functions. To determine how MKLP2’s divergent 236 
mechanochemistry functionally harnesses these subdomain movements, and to 237 
further characterise MKLP2’s differences compared to other kinesins, we examined 238 
the response of different regions of the MT-bound MKLP2-MD in different nucleotide 239 
states. 240 
 241 
Atypical response of MKLP2 catalytic site to nucleotide 242 
At the MKLP2-MD catalytic site, the nucleotide-dependent movement of three 243 
conserved, mobile elements that lie at the junction of the three subdomains can be 244 
tracked: 1) the P-loop (brown); 2) loop9 (yellow, contains Switch I); 3) loop 11 (red, 245 
contains Switch II) (Fig 3, Movie 2). The N-terminal half of helix-α4 lies at the back of 246 
the nucleotide-binding site and provides a structural link to the MT binding interface. 247 
These elements are sensors of the nucleotide present in the active site and also 248 
participate in the conformational response of the motor domain to nucleotide. 249 
 250 
The conformation(s) of MT-bound kinesins in the presence of ADP are still relatively 251 
poorly described (16) especially at high resolution, and depend on the MT affinity and 252 
kinetic behaviour of individual proteins. The properties of MKLP2-MD are such that 253 
an MT-bound MKLP2-MD-ADP structure could be captured, in which density 254 
corresponding to ADP is coordinated primarily via the P-loop with some connectivity 255 
to Switch II/loop11 (Fig 3, left; Fig2-figure supplement 1). A portion of loop11 is 256 
visible near the P-loop and the N-terminus of helix-α6, while most is not visible. This 257 
flexibility in loop11 is also seen in Kin1-ADP (30) and MT-bound Kin3-ADP (16). 258 
However, in MT-bound MKLP2-MD-ADP, loop9 as well as the N-terminus of helix-α4 259 
are more flexible compared to these other kinesin-ADP conformations, reflecting 260 
distinct properties of MKLP2-MD. 261 
 262 
Highly unusually, in the MKLP2-MD-NN structure, no major conformational 263 
differences are seen compared to MKLP2-MD-ADP (Fig 3, middle), although 264 
nucleotide density is clearly lacking from the active site (Fig2-figure supplement 1). 265 
Local differences due to subtle rotations in both the Switch I/II and the P-loop 266 
subdomains are seen (Fig 2D, middle), and helix-α4 is longer by ~1 turn compared to 267 
MKLP2-MD-ADP, but its N-terminal end along with most of loop11 are flexible. 268 
However, unlike in the ADP-bound structure, a region of Switch II density in loop11 269 
now appears connected to helix-α4. The connection to helix-α4 is close to the highly 270 
conserved ‘linchpin’ Asn (17) (N430 in mouse MKLP2, N255 in Kin1), is also seen in 271 
Kin1/3 NN states (16, 17, 29). In addition, density corresponding to the P-loop has 272 
shifted away from the MT surface, and while density corresponding to loop9 is 273 
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visible, with part of it contacting the P-loop (Fig 3, middle), loop9 does not adopt a 274 
defined conformation, due to flexibility. The overall disordered nature of the N-275 
terminus of helix-α4, loop 11 and loop 9 is very different from the more ordered 276 
conformation of these elements consistently seen in the MT-bound NN state of other 277 
plus-end kinesins (Fig3-figure supplement 1)(16, 17, 29, 31). Moreover, the well-278 
defined connectivity of loop11 and the MT surface seen in Kin1/3/5 NN states is not 279 
well ordered in MKLP2-MD. Thus, the MKLP2-MD-ADP and –NN structures are more 280 
similar to each other with respect to flexibility of MT binding elements at the helix-α4 281 
N-terminus and loop11 than is typical for other kinesins. 282 
 283 
Transition to the MKLP2-MD-ADP.AlFx structure causes substantial local 284 
rearrangements in the vicinity of the active site (Fig 3, right), which are in turn linked 285 
to large subdomain rearrangements compared to the ADP-to-NN transition (Fig 2D). 286 
These rearrangements can also be described by the configuration of clefts between 287 
the subdomains (17; Fig3 – figure supplement 2, see also discussion). First, density 288 
connects the P-loop and loop11 in the presence of bound nucleotide (Fig 3, right). 289 
However, in the presence of the ADP.Pi-like analogue, stable conformations for all 290 
components around the active site are also observed: density corresponding to the 291 
N-terminal end of helix-α4 and loop11 are seen and exhibit connectivity to adjacent 292 
regions (Fig. 3, right), while the N-terminus of loop11 runs past the P-loop, the -293 
phosphate mimic, and is connected to helix-α4, (Fig 3, right). The C-terminal end of 294 
loop11 forms a helical turn and density in this region connects to the N-terminus of 295 
helix-α6. There is also connectivity between the N-terminal end of helix-α4 and 296 
loop9, while the proximity of loop9 and loop11 is consistent with a ‘phosphate tube’ 297 
structure as seen in other ATP/ADP.Pi-like kinesin structures (26, 32–34). Overall, 298 
the compactness of the ATPase site is consistent with adoption of a catalytically 299 
competent conformation (34), similar to that seen in other kinesins, highlighting 300 
mechanochemical conservation within the superfamily with respect to closure of the 301 
active site to enable ATP hydrolysis. 302 
 303 
However, the MKLP2-MD-AMPPNP reconstruction illustrates another interesting 304 
divergence of MKLP2-MD mechanochemistry compared to Kin1/3 (Fig3 - figure 305 
supplement 3). In Kin1 and Kin3, the motor conformation in the presence of 306 
AMPPNP and ADP.AlFx are essentially indistinguishable (16, 26). However, in 307 
MKLP2-MD, while density corresponding to bound AMPPNP is observed (Fig2-figure 308 
supplement 1), none of the characteristic features in the motor observed for the 309 
catalytically competent ADP.AlFx conformation are seen upon AMPPNP binding. 310 
Instead, this reconstruction exhibits a similar conformation to the MKLP2-ADP and –311 
NN reconstructions, such that at the nucleotide binding site, helix-α4 shows a 312 
partially extended conformation and only some density corresponding to loop9 and 313 
loop11 is visible (Fig3-figure supplement 3B). This reconstruction thereby illustrates 314 
the large difference in structural response of MKLP2-MD to different ATP-like 315 
analogues - AMPPNP compared to ADP.AlFx – and is a further readout of the 316 
divergent properties of MKLP2. 317 
 318 
MKLP2 has a non-canonical MT binding interface and footprint on the MT surface 319 
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The divergent properties of MKLP2-MD are further emphasised in its interaction with 320 
the MT surface. The MKLP2-MD interface with the MT is composed of nucleotide-321 
invariant and nucleotide-sensitive elements. The nucleotide-invariant elements are 322 
formed by the tubulin-binding subdomain (Fig 2C,D). In this subdomain of MKLP2-323 
MD, a 5 aa insertion (Fig. 2A) both contributes an additional helical turn to the C-324 
terminus of helix-α4 and adds length to loop12 compared to Kin1 (Fig 4A); however 325 
this insert does not contact the MT. This C-terminus extension of helix-α4 is 326 
nucleotide-insensitive (Fig4-figure supplement1A,D) and thus is structurally similar to 327 
the helix-α4 extension formed by part of Kin3’s loop12 insert (16), although these 328 
insertions have no sequence homology.  329 
 330 
MKLP2-MD subdomain rearrangement in response to nucleotide (Fig 2D) causes 331 
nucleotide-dependent conformational changes in other elements at the MT binding 332 
interface. This includes movement of loop7 in the Switch I/II subdomain closer to the 333 
MT in the ATP-like state (Fig 4B, Fig4-figure supplement1B,E), and movement of 334 
helix-α6 in the P-loop subdomain relative to the MT surface (Fig 2D). As described 335 
above, however, in the vicinity of the nucleotide binding site, MKLP2-MD loop11 and 336 
helix-α4’s N-terminus are less ordered than in Kin1 in the absence of nucleotide (Fig 337 
3, Fig3-figure supplement1C, D, E).  338 
 339 
MKLP2’s Switch I/II subdomain also contains a 5 aa insertion in loop8 (Fig 2A), 340 
which is only well ordered in the presence of ADP.AlFx, and reaches across to 341 
contact H10-β9 of the neighbouring protofilament within the MT (Fig 4B, Fig4-figure 342 
supplement1B,E). To our knowledge MKLP2-MD is the first kinesin described where 343 
a monomeric motor domain can bridge across two protofilaments. MKLP2-MD also 344 
has a larger 18 aa insert (Fig 2A) in both the β-sheet1 and loop2 of the P-loop 345 
subdomain. In the NN and ADP states, density for this insert is not visible unless 346 
much less conservative thresholds are used, indicating greater flexibility of loop2 in 347 
these two states (Fig4-figure supplement1C,F). In the presence of ADP.AlFx, density 348 
for this element extends from the minus end of the MKLP2-MD and connects to α-349 
tubulin (Fig 4C), consistent with the large rotation of the P-loop subdomain in this 350 
ADP.AlFx state (Fig 2D).  351 
 352 
Compared to Kin1, not only does the MKLP2-MD contain extra sequences that 353 
contact the MT, but the precise position and orientation of MKLP2-MD as a whole is 354 
also noticeably shifted and rotated on the MT surface (Fig 4D). A similar shift and 355 
rotation is present in both our MT-bound NN and ADP.AlFx MKLP2-MD 356 
reconstructions (Fig4-figure supplement2), and is therefore independent of the 357 
nucleotide-dependent conformational changes. This shift and rotation particularly 358 
alters the MT interface of MKLP2-MD near the nucleotide binding pocket. For 359 
example, in MKLP2-MD, loop7 is closer to β-tubulin (Fig 4E) compared to Kin1, while 360 
the ordered single-turn helix in loop11 is closer to H3 than H12 in α-tubulin in the 361 
MKLP2-MD-ADP.AlFx state (Fig 4F).  362 
 363 
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Altogether, both kinesin-conserved and MKLP2-MD-specific elements contribute to 364 
the motor’s interaction with the MT, several of which are nucleotide sensitive. The 365 
collective effect of MKLP2-specific modifications leads to the shift and rotation of the 366 
MKLP2-MD on the MT surface. The differences in MKLP-MD compared to Kin1 also 367 
modify its footprint on the MT surface, leading to MKLP2-MD contacting a greater MT 368 
surface area in all states (Fig 5; Fig5-figure supplement1). The enhancing effect of 369 
the shift and rotation (Fig.4D) is most clearly seen in the increased footprint of loop7 370 
and α4 (in both NN and ADP.AlFx states), and loop11 in the ADP.AlFx state (Fig 5, 371 
Fig5-figure supplement1). The transition from NN to ADP.AlFx states and further 372 
rotation of the Switch I/II subdomain brings loop7 and loop8 into even more extensive 373 
contact with β-tubulin’s H4, while full ordering of helix-α4 and loop11 adjacent to the 374 
active site leads to additional contacts with α-tubulin. Moreover, ordering of MKLP2-375 
specfic insertions that are present in the ADP.AlFx reconstruction produce a further 376 
enhancement of the MKLP2-MD footprint (Fig 5). In addition to the enlarged footprint 377 
of MKLP2-MD on the negatively charged MT surface (19), the electrostatic surface of 378 
MKLP2-MD shows a more pronounced positive interaction surface compared to 379 
kinesin-1, especially around the C-terminal end of helix-α4, a region that is nucleotide 380 
invariant. Thus, through its ATPase cycle, the footprint of MKLP2-MD on the MT is 381 
altered and is most different in its ATP-like state.  382 
 383 
Divergence of MKLP2 motor domain structural response to nucleotide: neck-linker 384 
and N-terminus 385 
Nucleotide-dependent subdomain rearrangements in MKLP2-MD yield 386 
conformational changes at both termini of the motor. This includes opening of the 387 
cleft between the P-loop and tubulin-binding subdomains that can accommodate 388 
neck-linker reorientation and docking upon ATP binding (Fig 6). With ADP bound, as 389 
for other kinesins, the C-terminal helix-α6 lies close to the motor-MT interface and 390 
terminates adjacent to the C-terminus of helix-α4 (Fig 6A, arrow). The density for 391 
helix-α6 is less well-defined, with a length of three helical turns at most and is thus 392 
shorter than typically seen in other kinesins (Fig 6A, arrowhead; (16, 17)). In this 393 
configuration, extension of helix-α6, docking of the neck-linker and formation of the 394 
cover-neck bundle (CNB) are all prevented. Strong density corresponding to only a 395 
few residues of each of the N- and C-termini is observed, although additional density 396 
alongside β-sheet1 is visible suggesting partial occupancy of neck-linker conformers 397 
directed towards the MT minus end (Fig 6A, dotted line). In the NN reconstruction, 398 
the overall organisation of this region is very similar to that in the ADP state (Fig 6B) 399 
(and of the AMPPNP state, Fig6-figure supplement1), although density 400 
corresponding to helix-α6 is better defined in the NN compared to the ADP structure.  401 
 402 
Following the subdomain rearrangement accompanying the NN/ADP.AlFx transition, 403 
the neck-linker cleft opens. Helix-α6 of MKLP2-MD extends beneath the core β-404 
sheet, thereby directing the neck-linker towards the MT plus end (Fig 6C). This is 405 
consistent with the presence of a conserved cluster of hydrophobic residues in helix-406 
α4, helix-α6 and the N-terminus that form a structural pocket that accommodates the 407 
helix-α6 extension and neck-linker reorientation (Fig 6D). This is also consistent with 408 
orientation of the N-terminus towards the MT plus end and formation of the CNB. The 409 
density of these N-terminal residues corresponds to S61-V64 and for the neck-linker 410 
corresponds to Q505-H508. In support of partial docking and reorientation of the 411 
 11 
neck-linker, anisotropy decay curves show that the MKLP2-MD neck-linker becomes 412 
more ordered in the presence of ADP.AlFx - as shown by the increase in rotational 413 
correlation time - compared to the absence of nucleotide, and depends on MT 414 
binding (Fig 6E).  415 
 416 
Strikingly, however, density corresponding to C-terminal residues extending from 417 
around H508, which would correspond to a docked neck-linker conformation, is not 418 
visible in the ADP.AlFx density map (Fig 6F). Residues of the MKLP2-MD extended 419 
N-terminus prior to S61 are also not visible. Consistent with a non-canonical neck-420 
linker conformation, the neck-linker sequence itself differs markedly from other plus-421 
end kinesins (Fig 6D). Most plus-end directed kinesins have a conserved sequence 422 
in which two Asn residues make hydrogen bonds against the core, stabilizing neck-423 
linker docking (26) (Fig6D, Fig6-figure supplement2). In MKLP2, these two Asn 424 
residues have been substituted for basic His residues, which would be predicted to 425 
preclude neck-linker docking. In addition, conserved core residues contacting this 426 
region of the neck-linker in plus-end directed kinesins are not fully conserved in 427 
MKLP2; for example Kin1-Y77MKLP2- Q151 (Fig 6D). Thus, although subdomain 428 
rearrangement results in reorientation of the MKLP2-MD neck-linker towards the MT 429 
plus end – as with other plus end kinesins – the docking of the neck linker that is 430 
typically seen does not occur in MKLP2-MD.  431 
 432 
MKLP2 loop6 forms a distinct subdomain 433 
Loop6 is the largest MKLP2-specific insertion (99 aa) and density corresponding to it 434 
is present in all nucleotide states (Fig 7, Fig7-figure supplement1). The higher 435 
resolution of the ADP.AlFx reconstruction facilitates the characterisation of density 436 
corresponding to loop6 (Fig 7A,B, Movie 3), which emerges from the side of the 437 
motor domain facing the MT plus end. Given its position, connectivity and its 438 
apparent movement in the NN/ADP.AlFx transition, it is effectively part of the SwI/II 439 
subdomain (Fig 7C). Loop6 forms density that spreads across the MT-facing surface 440 
of the central β-sheet. This density also connects the MT facing surface of the core 441 
β-sheet with β-sheet-5a/b of the tubulin-binding subdomain that connects to the MT 442 
surface (Fig 7B). However, loop6 itself does not appear to contact the MT surface. 443 
Creating a full model of loop6 was not possible, but secondary structure prediction of 444 
loop6 converged on the presence of a 4-turn helical region towards its N-terminus 445 
(Fig7-figure supplement1E). Density that corresponds to a helical structure was 446 
observed lying close to helix-α3 and we modelled an α-helix within it (Fig 7A,B). 447 
However, the rest of loop6 has no predicted secondary structure and may be 448 
intrinsically disordered (35). As displayed in Fig 7A,B, loop6 is incompletely 449 
visualised, partly due to the lack of discrete secondary structural elements and also 450 
presumably due to flexibility in this region of the motor. This conclusion is reinforced 451 
when, with coarser (low-pass) filtering of the EM reconstruction, a large and lower 452 
resolution cloud of density is revealed (Fig 7D), consistent with what was previously 453 
described from a 2.5nm resolution reconstruction of the C. elegans kinesin-6, MKLP1 454 
(Zen4) (12). This density is unconnected to other regions of the motor domain, and 455 
does not contact adjacent motor domains or the MT, but likely corresponds to 456 
multiple flexible conformations of the remaining loop6 residues.  457 
 458 
  459 
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DISCUSSION 460 
While the cell biological contributions of MKLP2 and other kinesin-6s during mitosis 461 
are increasingly well understood, little has been known about the molecular 462 
mechanism of these divergent mitotic motors. Using cryo-EM to generate structures 463 
that guide comparative modelling and flexible fitting, we have been able to visualise 464 
sequential states of the MT-bound MKLP2-MD ATPase cycle. Our structural 465 
dissection of a mammalian MKLP2-MD allows identification of aspects of its 466 
mechanism that appear conserved among kinesins along with many properties that 467 
differ substantially from other members of the superfamily.  468 
 469 
Our set of structures allows us to characterise the response of the track-bound 470 
MKLP2-MD to nucleotide. Some aspects of its nucleotide-dependent conformational 471 
responses appear to be similar to Kin1/3/5, and can be framed in terms of relative 472 
movements of subdomains within the motor domain and the clefts that open and 473 
close between them (Movie 1, Fig 6, Fig3-figure supplement 2) (17, 29). The so-474 
called nucleotide cleft (NC) that lies between the Switch I/II and P-loop subdomains 475 
is predicted to close in the presence of bound nucleotide and to open in its absence. 476 
The polymer cleft (PC) lies between the tubulin-binding and the Switch I/II 477 
subdomains; it is closed in the presence of a close interaction between helix-α4 and 478 
SwII and open in its absence, and is proposed to change at different points in the 479 
MT-bound kinesin ATPase cycle. The docking cleft (DC) lies between the P-loop and 480 
tubulin-binding subdomains and when open allows insertion of helix-α6 and 481 
reorientation of the neck-linker towards the MT plus end (17). Thus, for MKLP2-MD: 482 
i) in the ADP-bound structure, the PC is open, while the NC is closed and the DC for 483 
the neck-linker is also closed; ii) in the NN state, the PC is closed while the NC is 484 
open, such that the DC remains closed; iii) in the ADP.AlFx state in which the active 485 
site is closed in a catalytic-competent conformation, both the PC and NC are closed 486 
leading to an opening of the DC and reorientation of the neck-linker towards the MT 487 
plus end. Our MKLP2-MD structures thus reinforce the logic of cleft opening/closure 488 
with respect to kinesin mechanochemistry first described for Kin1 (17), while 489 
demonstrating an elaboration of motor function through family-specific modifications. 490 
 491 
The biochemistry of MKLP2 is highly divergent compared to canonical kinesins. The 492 
kcat of MKLP2-MD (4.4 s
-1) is ~10-fold lower than kinesin-1 and -3 (Table 1) and a 493 
number of MKLP2-MD substitutions at otherwise highly conserved regions could 494 
influence multiple steps in its catalytic cycle. For example, MKLP2-MD has low ADP 495 
affinity in solution and this is barely altered on interaction with MTs. Indeed, the ADP 496 
release rate in the absence of MTs is only 2-3-fold less than that for as high as 497 
Kin1/3s in the presence of saturating MTs. Thus, while MT binding activates the 498 
MKLP2 ATPase, its basal ADP release rate is higher than kcat. The small structural 499 
changes observed when comparing our ADP and NN structures – in particular, that 500 
the N-terminus of helix-α4 and loop11 remain largely disordered in the NN state – is 501 
a distinctive property of these MKLP2/MT complexes compared to other plus end 502 
kinesins (Figure3-figure supplement1 (16–18, 29)). Substitutions at conserved sites 503 
around the nucleotide pocket might be predicted to destabilise the nucleotide binding 504 
network that is present in other kinesins. For example, substitution in loop9 at a 505 
residue otherwise completely conserved in all kinesins (Kin1-R190MKLP2-Q365, 506 
Figure3-figure supplement1A) could perturb side chain interactions proposed to be 507 
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part of the so-called “Mg2+ stabiliser” (33). Indeed, mutagenesis of this network in 508 
Kin1 (29) or Kin3 (36) increases ADP release rates in the absence of MTs. Similarly, 509 
substitutions in and around the P-loop (Kin1-A83 MKLP2-T157 and Kin1-Q86 510 
MKLP2-V160), along with helix-α6 (Kin1-N308MKLP2-T489) may perturb the 511 
stability of loop11/P-loop at the active site through alteration of the so-called “anchor” 512 
network (33). Loop11 itself is one residue shorter than in other N-kinesins, adopts a 513 
different conformation compared to Kin1 and contains substitutions in residues that 514 
contribute to stabilisation of Kin1’s ordered conformation in the NN and ATP-like 515 
states (Kin1-T241MKLP2-Q417, and Kin1-A243MKLP2-S419, Figure3-figure 516 
supplement1A). We conclude that the collective effect of these substitutions – along 517 
with possible effects from the shift of MKLP2-MD binding on the MT surface – is 518 
likely to be the reason for lower stabilisation of nucleotide binding to MKLP2-MD.  519 
 520 
Given these properties, it is thus not clear what state our ADP-bound reconstruction 521 
corresponds to in terms of intermediates in the MKLP2 ATPase cycle. It could for 522 
example be the MKLP2-MD-ADP complex as it binds the MT from solution, or could 523 
represent a MT-bound NN structure captured after ADP binding. Given the fast 524 
kinetics of ADP release by MKLP2-MD, the latter seems more likely. Therefore, 525 
previously proposed mechanisms of MT-stimulated ADP release in Kin1/3s may not 526 
be applicable to MKLP2-MD (16, 17, 29). Nevertheless, the position of the P-loop is 527 
shifted away from the MT in the MKLP2-NN structure compared to the ADP-bound 528 
structure and the PC is closed, conformational changes that were described to 529 
coincide with ADP release in Kin1 (17, 29). While apparently redundant in actively 530 
driving ADP release in MKLP2, these cleft and subdomain transitions when ADP is 531 
absent may still be important for subsequent larger scale rearrangements in the 532 
motor domain on ATP-binding and its conversion towards a hydrolysis-competent 533 
state.  534 
 535 
The structure of the MKLP2-MD-ADP.AlFx reconstruction suggests that MT binding 536 
participates in stabilising helix-α4 and loop11 in this structure, supporting the 537 
conserved SwitchI/II and P-loop residues in adopting a catalytically relevant 538 
conformation. The MKLP2-ADP.AlFx reconstruction is overall comparable to 539 
hydrolysis-competent conformations seen in Kin1/3/4/5 with a so-called phosphate 540 
tube formed from loop9 and 11 supporting ATP hydrolysis. However, the 541 
reconstruction in the presence of AMPPNP most closely resembles that of ADP – 542 
rather than ADP.AlFx as is seen in Kin1/3 – and it may also represent the MKLP2-543 
MD NN conformation after AMPPNP has bound to it. This too could be a reflection of 544 
MKLP2-specific substitutions within and around the nucleotide binding site (Figure3-545 
figure supplement1) that influence the binding kinetics and structural transitions of 546 
MT-bound MKLP2-MD in response to different nucleotides, and which also contribute 547 
to the overall turnover rate of the motor’s ATPase. Precedents for different responses 548 
to different nucleotide analogues have also been observed in other kinesins – for 549 
example, small differences in motor conformation between AMPPNP and ADP.AlFx 550 
were observed for human Kin5 (18). Future detailed kinetics will yield further insights 551 
into the defining transitions of MKLP2 during its ATPase cycle. 552 
 553 
The MKLP2-MD steady state ATPase activity shows that its K0.5,MT is ~1.1M. This 554 
agrees well with the co-sedimentation analysis, which also shows that, while the 555 
 14 
affinity is higher in the NN and AMPPNP states, there is less effect of nucleotide on 556 
the overall affinity of the MKLP2-MD for MTs compared to Kin1. Our reconstructions 557 
do not provide obvious structural explanations for these subtle nucleotide-dependent 558 
differences in the MT affinity of MKLP2-MD. Indeed, the additional MKLP2-MD loop 559 
contacts with the MT were modelled most easily in the highest resolution 560 
reconstruction (ADP.AlFx), which has a slightly lower MT affinity. It is thus possible 561 
that the flexible loops formed by the MKLP2-MD specific insertions do not directly 562 
contribute to differences in affinity in this motor compared to Kin1; rather this is 563 
dominated by the differences in the surface charge of the MT interface (Fig 5). 564 
Further insight concerning the effects on the kinetics of structural transitions induced 565 
by different nucleotides will be required to fully dissect these effects.  566 
 567 
MKLP2-MD K0.5,MT is ~10 fold lower than the Kin1 motor domain (13M) (16). While 568 
both motors bind MTs via their conserved tubulin-binding subdomains, strikingly the 569 
MKLP2-MD MT interface is overall more positively charged than that of Kin1, which 570 
likely contributes to the overall increased affinity of MKLP2 throughout the ATPase 571 
cycle. In addition, the MKLP2-specific, nucleotide invariant extension of loop12 is 572 
positively charged and may interact with the nearby acidic C-terminal tails (CTTs) of 573 
-tubulin, although there is no visible connection in our reconstructions, likely due to 574 
its conformational variability. A similar interaction between the -tubulin CTT and 575 
loop12 of Kin3 has previously been described (37), although Kin3 loop12 has a 576 
higher net positive charge (+4) than MKLP2 and is longer and conformationally 577 
flexible in all nucleotide states (16). Sequence insertions within loop2 are more 578 
usually associated with depolymerisation activity, for example in Kin13s (38), but 579 
here MKLP2-MD loop2 appears to simply form a MT contact, with no current 580 
evidence of MKLP2 activity influencing MT dynamics. In addition to these loop 581 
insertions creating additional MT contacts with the primary tubulin binding site, 582 
MKLP2-MD loop8 can reach to contact an adjacent protofilament.  583 
 584 
The collective effects of all the differences between MKLP2-MD and Kin1/3 manifest 585 
in the striking observation of bound MKLP2-MD shifted rotationally and translationally 586 
relative to the MT surface in all nucleotide states, creating a different footprint on the 587 
MT surface. This produces altered interactions across the MT surface including in 588 
loop11 adjacent to the active site and, together with the MKLP2-specific 589 
modifications around the active site, may have a knock-on effect on the catalytic 590 
activity of the motor. Thus, wWhile not sufficient to perturb the fundamentals of 591 
nucleotide-sensitive subdomain rearrangement or formation of a hydrolysis 592 
competent conformation at the active site, MKLP2-MD altered position on the MT 593 
surface may regulate the transition rates between structural states. The altered 594 
footprint may also enable MKLP2 to select different populations of MT tracks within 595 
the spindle for interaction. Thus, our structural characterisation of MKLP2-MD 596 
suggests that the binding site of kinesins on the MT surface has some previously 597 
unsuspected plasticity that enables tuning of motor function while still supporting 598 
conserved conformational changes. 599 
 600 
In Kin1/3/5, the key conformational change elicited by ATP binding to MT-associated 601 
motors is ordering of the neck-linker towards the MT plus end (39). Such neck-linker 602 
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docking is supported by formation of the CNB between the neck-linker and the motor 603 
domain N-terminus (40). In MKLP2, reorientation of the neck-linker and CNB 604 
formation occur in the presence of ADP.AlFx and the neck-linker is less mobile than 605 
in other nucleotide states (Fig 6E). This is despite the shortness of helix-α6 in the 606 
ADP/NN states and substitution of Kin1-K323MKLP2-S504 at the transition 607 
between helix-α6 and neck linker. CNB formation is, however, consistent with 608 
conservation across all N-kinesins including MKLP2 of a cluster of hydrophobic 609 
residues in this region of the motor domain (Fig 6 (41)). Formation of the CNB also 610 
contributes to stable closure of the nucleotide binding pocket and supports ATPase 611 
activity (29).  612 
 613 
Remarkably, however, the distal region of the putative MKLP2-MD neck-linker does 614 
not visibly dock along the plus end portion of the motor domain core, and 615 
demonstrates residual flexibility despite CNB formation. This observation is 616 
consistent with the divergent MKLP2 sequences both in the neck-linker and along the 617 
core β-sheet where the neck-linker might otherwise dock (Fig 6D, Figure6-figure 618 
supplement2) (42)). Furthermore, the MKLP2-MD neck-linker also contains two 619 
adjacent proline residues (P510 and P511) that are likely to affect the conformation 620 
of the neck-linker. Divergence in the distal neck-linker region is a feature of the 621 
MKLP2 sequence in a number of organisms (Figure6-figure supplement2). Indeed, 622 
our structural findings suggest that analysis of sequences immediately C-terminal of 623 
kinesin motor domains could be considered in two segments according to 1) CNB 624 
formation by the proximal region and 2) docking of the distal region, when predicting 625 
motor function. It is not known if dimers of MKLP2 operate by taking steps in the 626 
same way as characterised for transport kinesins, and our structures predict that the 627 
molecular properties of full length MKLP2 are likely to be distinct from Kin1. In 628 
addition, the MKLP2 neck region – separating the neck-linker and the coiled coil – is 629 
substantially longer (~40 residues) than for example Kin1, making it unlikely that 630 
conventional models of processive stepping apply to MKLP2.  631 
 632 
An extended loop6 insertion is characteristic of kinesin-6s and was visible in our 633 
MKLP2 reconstructions, with its location and its partial conformation visualised both 634 
at lower and higher resolutions, respectively (Fig 7, Movie 3). In addition, sequence 635 
analysis suggests that the N-terminal helical portion of loop6 is also likely to be 636 
conserved in MKLP2s in metazoa (Fig7-figure supplement1E). During preparation of 637 
our manuscript, a structural snapshot of the C. elegans kinesin-6 Zen4 motor domain 638 
in the absence of its MT/tubulin track was published (43). Intriguingly, although the 639 
loop6 insertion of this MKLP1 relative is substantially shorter than in MKLP2, a 640 
helical segment is also observed in this region of Zen4, consistent with our 641 
predictions. However, the connectivity of loop6 in the two kinesin-6s is different, with 642 
MKLP2 loop6 forming much more extensive contacts with other regions within the 643 
SwI/II subdomain. This leaves open the question as to this loop’s functional 644 
contribution to MKLP2. Given its connectivity with more conserved portions of the 645 
motor domain such as loop8/beta-5, it could have an overall modulatory role on 646 
motor mechanochemistry. It is also possible that it is the binding site for other 647 
regulatory components of the central spindle. Sequence comparisons informed by 648 
our structural data suggest that the presence of loop6, other extended insertions 649 
including loop2, and modifications related to neck-linker docking are highly 650 
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characteristic of this subfamily of motors. Thus, our structural data shed light on the 651 
unusual mechanochemistry of the MKLP2-MD and could be used to predict the 652 
properties of other members of the kinesin-6 subfamily, including the two other 653 
kinesin-6 family members within vertebrates. Similarly, sequence analysis in the 654 
structural context of one highly divergent kinesin subfamily can also be mapped onto 655 
other members of the wider superfamily.  656 
 657 
Our structural and biophysical characterisations of the MKLP2 motor domain suggest 658 
that this protein and its relatives could act as an organiser or a tension sensor, rather 659 
than a classical transport motor, within the MT bundles at the spindle midzone. A 660 
non-transport role for kinesin-6s was also implied by recent computational analysis of 661 
the kinesin superfamily (44). Nevertheless, MKLP2 inhibitor studies highlight the 662 
importance of the ATPase activity of MKLP2 for its role within the spindle, suggesting 663 
that the nucleotide-dependent conformational changes we have described are 664 
important for its mitotic function (11). The atypical mechanochemistry of MKLP2 665 
could also facilitate the motor’s response to signalling cues throughout cell division, 666 
especially as mitosis proceeds towards cytokinesis. In combination with the capacity 667 
of its C-terminal region also to bind MTs (45), teams of MKLP2 motors in the spindle 668 
midzone could contribute to collective sliding and organisation of the dense collection 669 
of MTs found there. The altered footprint of MKLP2-MD binding on the MT surface 670 
may influence MT bundle organisation in this context. The activity of MKLP2 is also 671 
subject to numerous points of post-translational modification and regulation by mitotic 672 
kinases, including within or near the motor domain. For example, a Cdk1 site (T197) 673 
is located within loop6 in the connecting region between the body of the motor 674 
domain and the α-helix visualised in our reconstruction (3), while a Plk1 site/binding 675 
site is in the neck region beyond the neck linker (S527) where other binding partners 676 
are known to interact. Such modifications could also fine tune the mechanochemistry 677 
of MKLP2 and regulate its precise function. Our characterisation of MT-bound 678 
mammalian MKLP2 by cryo-EM sets the structural stage for future studies to further 679 
dissect the mechanism, function and regulation of this divergent mitotic kinesin. 680 
 681 
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 700 
MATERIALS AND METHODS 701 
Protein expression, purification, and labelling 702 
The MKLP2 constructs were cloned into a pET28 vector with C-terminal 6His tag and 703 
expressed in BL21 Gold (DE3) E. coli cells by induction with 0.2 mM IPTG at 20°C 704 
overnight. Cells were harvested by centrifugation at 4500×g for 10 min and lysed by 705 
sonication in lysis buffer (50 mM HEPES, pH 7; 500 mM NaCl, 40 mM Imidazole, 1 706 
mM TCEP, 0.5 mM PMSF, 0.1 mM ADP, 5 mM MgCl2). The lysate was clarified at 707 
20,000×g for 45 min at 4°C; and the protein was purified by HisTrap column (GE 708 
Healthcare Life Science). Further purification was achieved by size exclusion 709 
chromatography in buffer containing 20 mM HEPES pH 7, 100 mM NaCl, 1 mM 710 
TCEP, 5 mM MgCl2, and 0.1 mM ADP.  Fractions containing purified MKLP2 protein 711 
were pooled and concentrated to ~10 mg/ml, flash-frozen in liquid nitrogen and 712 
stored in -80 °C until usage. For anisotropy decay studies, the 25-520 MKLP2-MD 713 
construct was modified by inserting the sequence CCPGCC at its C-terminus before 714 
the His tag sequence. The construct was expressed and purified as above. It was 715 
labelled with the fluorescein derivative FlAsH (Molecular Probes) by incubation of a 716 
10-fold molar excess of label over protein in 25 mM HEPES, 50 mM KAc, 5 mM 717 
MgAc, pH 7.5 for 12 hours followed by removal of unbound label over prepoured 718 
Sephadex G25 columns (GE Healthcare). The stoichiometry of labelling was typically 719 
0.8-0.9 FlAsH:MKLP2-MD. 720 
 721 
Steady state ATPase, Transient Kinetic Methodologies  722 
MKLP2 construct ATPase activities were determined, in duplicate, in a buffer 723 
containing 50 mM KAc, 25 mM HEPES, 5 mM MgAc, and 1 mM EGTA, pH 7.5 (RT) 724 
by measuring released phosphate using a commercial kit (EnzChek Phosphate 725 
Assay, Molecular Probes). Binding of the fluorescent nucleotide analogues 2’dmT (in 726 
duplicate) and 2’dmD (once) to 4:1 complexes of MTs:MD were measured by mixing 727 
with an excess of fluorescent nucleotide in the stopped flow at 20oC. Samples were 728 
rendered nucleotide free prior to mixing by incubating for 20 minutes with 0.2 U/ml 729 
apyrase (Type VII, Sigma Aldrich). Fluorescence enhancement of the mant 730 
fluorophor was monitored by energy transfer from vicinal tryptophans by exciting at 731 
295 nm and monitoring 90o from the incident beam through a 450 nm broad 732 
bandpass filter (Omega Optical). Data were subjected to linear least squares fitting. 733 
Dissociation of 2’dmD from MKLP2-MD was measured by adding a 10-fold molar 734 
excess of 2’dmD to MKLP2-MD in ATPase buffer and mixing with 2 mM MgADP.  735 
The resulting fluorescence decrease was monitored by energy transfer from vicinal 736 
tryptophans by exciting at 295 nm and monitoring 90o from the incident beam through 737 
a 450 nm broad bandpass filter (Omega Optical). 738 
 739 
MT co-sedimentation assay 740 
Tubulin (Cytoskeleton Inc, Denver, CO) was resuspended in BRB80 (80 mM PIPES, 741 
2 mM MgCl2, 1mM EGTA, 1 mM DTT) to 50 M. Polymerization of tubulin into MTs 742 
was carried out by addition of 1 mM GTP and incubated at 37°C for 1hr, followed by 743 
addition of 200 M paclitaxel (Cytoskeleton) and additional incubation for 1h at 37°C. 744 
Paciltaxel-stabilized MTs were kept at room temperature for >24hrs, centrifuged at 745 
15,000×g for 30 min, and resuspended to 100 M with BRB80 buffer plus 200 M 746 
paclitaxel. Equilibrium binding experiments were performed at 25°C in BRB80 buffer 747 
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plus 25 mM NaCl (all concentrations reported as final values after mixing). MKLP2-748 
MD was incubated with ADP or ADP.AlFx for 30 min. For NN sample, MKLP2-MD 749 
was first treated with apyrase to remove all bound nucleotides. 2.5 M MKLP2-MD in 750 
different nucleotide state was incubated with paclitaxel-stabilized MTs (0–10 M 751 
polymerized tubulin; 20 M paclitaxel) in a 100-l reaction with 1 mM corresponding 752 
nucleotide. The mixture was incubated for 30 min and centrifuged at 100,000×g for 753 
30 min at 25 °C. The supernatant was removed and the pellet was gently rinse with 754 
warm BRB80 buffer plus 20M paclitaxel. The pellet was resuspended in cold 755 
BRB80 buffer plus 10 mM CaCl2. The supernatant and pellet from each sample were 756 
analysed on SDS-PAGE gels. The concentrations of MKLP2-MD in the supernatant 757 
and pellet were quantified using Image J software. GraphPad Prism was used for 758 
curve fitting using a quadratic function that assumes 1:1 MD:tubulin binding 759 
stoichiometry: 760 
 761 
 762 
where MDbound is [MKLP2-MD] bound to MTs, MDtotal is total MKLP2-MD in the assay, 763 
MTtotal is total MT content in the assay, and KD is the dissociation constant for binding. 764 
 765 
Time-resolved Fluorescence Anisotropy 766 
Time-resolved fluorescence anisotropy (TFA) data were acquired as described 767 
previously (46) using 9 M FlAsH labeled MKLP2-MD (85% labeled) in the presence 768 
or absence of 15 M MT. Single exponential functions to the nanosecond FlAsH 769 
anisotropy decays of labelled MKLP2-MD were fitted for: i) bound to MTs in the 770 
absence of nucleotide, ii) in the presence of ADP.AlFx in solution or iii) bound to MTs 771 
in the presence of ADP.AlFx. The buffer used was 25 mM HEPES, 50 mM KAc, 5 772 
mM MgAc, pH 7.5. Anisotropy decays were acquired from two independent 773 
preparations of protein. For each biochemical condition assayed, a minimum of 5 774 
independent samples were acquired. Data were subjected to non-linear optimization 775 
to determine best fitting single exponential decay parameters. Data reported 776 
represent the mean of parameters from fits of replicate data +/- the standard error for 777 
the fit parameter.  778 
 779 
Cryo-EM sample preparation 780 
MTs for MKLP2-MD ADP.AlFx, AMPPNP and no nucleotide data sets were 781 
polymerized by incubating 50 μM bovine tubulin (Cytoskeleton Inc, Denver, CO) in 782 
MES polymerization buffer (100 mM MES, pH 6.5, 1 mM MgCl2, 1 mM EGTA, 1 mM 783 
DTT, 5 mM GTP) for 1hr at 37°C. GMPCPP MTs used for the MKLP2-MD ADP 784 
dataset were double-cycled by polymerizing 20 μM bovine tubulin in BRB80 buffer 785 
with 1mM GMPCPP for 45 mins at 37°C, depolymerizing on ice and repolymerizing 786 
for a further 45 mins with an additional 2 mM GMPCPP. 1 mM paclitaxel was then 787 
added to all MT preps, incubated for a further 1hr at 37°C, and left at room 788 
temperature for 24-48hrs before use. MTs were diluted to a final concentration of 2.5 789 
μM in BRB80 buffer. MKLP2-MD was buffer exchanged into BRB20 (20mM PIPES, 790 
2mM MgCl2, 1mM EGTA, 1mM DTT) containing either 2 mM of AMPPNP, ADP, ADP 791 
+ AlF4, or apyrase (10 units/ml), diluted to a final concentration of 60 μM MKLP2-MD 792 
and left for 15 minutes at room temperature before use. MT and MKLP2-MD samples 793 
 20 
were added in a sequential fashion as 4 μl droplets to glow-discharged C-flatTM holey 794 
carbon EM grids (Protochips) before blotting and plunge-freezing in liquid ethane 795 
using a Vitrobot (FEI Co.).  796 
 797 
Cryo-EM data collection and data processing 798 
Images of MKLP2-MD ADP, ADP.AlFx and NN states were collected on a FEI Tecnai 799 
G2 Polara operating in low dose mode at 300kV, using a DE20 direct electron 800 
detector (Direct Electron) with a final sampling of 1.53Å/pixel. A total electron dose of 801 
~50e-/Å2 over a 1.5s exposure at 15 frames/s gave a total of 22 frames, at ~2.2e-/Å2 802 
per frame. Images of the MKLP2-MD-AMPPNP state were collected on a FEI Tecnai 803 
F20 operating in low dose mode at 200kV using a DE20 direct electron detector 804 
(Direct Electron) with a final sampling of 1.54Å/pixel. A total electron dose of ~40e-805 
/Å2 over a 1s exposure at 25 frames/s gave a total of 25 frames, at ~1.6e-/Å2 per 806 
frame.  807 
 808 
To correct for sample drift and local beam induced movement respectively, individual 809 
frames were globally aligned using IMOD (RRID:SCR_003297) scripts, then locally 810 
aligned using the Optical Flow approach implemented in Xmipp (47). The full dose 811 
was used for particle picking and CTF determination using CTFFIND3 (48), while 812 
25e-/Å2 or 20e-/Å2 were used for particle alignment, angular assignment and 3D 813 
reconstruction on data collected at 300kV or 200kV respectively. MT segments 814 
selected in Eman boxer served as input to a set of custom-designed semi-automated 815 
single-particle processing scripts utilizing Spider and Frealign as described 816 
previously, with minor modifications (16, 17, 32). Poorly aligned particles were 817 
excluded from final reconstructions according to Frealign’s reported phase-residual 818 
values. The final dataset size (in asymmetric units) are: MKLP2-MD-ADP – 137,788; 819 
MKLP2-MD-NN – 120,341; MKLP2-MD-ADP.AlFx – 276,111; MKLP2-MD-AMPPNP 820 
– 141,154. The resolutions of symmetrized reconstructions are shown in Figure 2-821 
figure supplement1A-D. The binding surfaces of kinesin/MTs in these final structures 822 
were coloured according to the electrostatic potential as calculated with pdb2pqr (49) 823 
and APBS (50). 824 
 825 
Sequence analysis and modelling of MKLP2-MD 826 
As shown in Figure 2-figure supplement 32, 100 homology models for each 827 
nucleotide state were generated with MODELLER v9.15 (RRID:SCR_008395) (51) 828 
using multiple templates (Table 2). Templates were selected based on sequence 829 
identity and structural identity (inferred from secondary structure predictions made 830 
using Psipred (RRID:SCR_010246), Jpred, and RaptorX, (52–54)). In addition, the 831 
two crystal structures of kinesin-1-/tubulin complexes in ADP.AlFx (26) or no 832 
nucleotide states (29) were selected as templates to capture the nucleotide/tubulin-833 
dependent conformations of the motor domain; and were verified as a suitable 834 
templates by rigid fitting into MKLP2-MD densities. Given the low sequence identity 835 
of MKLP2-MD to the identified templates (28-34%), sequence alignment was initially 836 
performed in MUSCLE (RRID:SCR_011812) (55), then manually adjusted, based on 837 
conserved motor domain residues identified in the Pfam database (version 29.0) 838 
(56). For each nucleotide state, the 10 best models from MODELLER were selected 839 
using SOAP scoring (57), and QMEAN (58) was then used to determine the top 840 
model. Global QMEAN scores indicated the models were of good quality (Table 2). 841 
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 842 
Flexible fitting of models in cryo-EM reconstructions 843 
The fitted MKLP2-MD models were first refined without tubulin (tubulin density was 844 
removed using Segger (59) in Chimera (RRID:SCR_004097) (60). Owing to the size 845 
and likely disordered nature of the most of loop6, we did not model it. To avoid loop6 846 
density biasing modelling, the difference mapping function in the TEMPy software 847 
package (61, 62) was used to remove the density.  848 
 849 
The Fit in Map tool (63) in Chimera was used to perform a rigid fit of the homology 850 
models into EM maps filtered to appropriate resolution (ADP.AlFx = 5.5Å, no 851 
nucleotide = 7Å, ADP = 7Å, AMPPNP = 8Å). The quality of fit was assessed using 852 
SMOC scoring in the TEMPy. This identified several MKLP2-MD loop insertions 853 
associated with poor fit. Where loops had clear corresponding density, 100-500 loop 854 
conformers were calculated using MODELLER’s loop model class (64), and were 855 
ranked and selected based on improved cross-correlation. A hybrid approach to 856 
flexible fitting was performed using simulated annealing molecular dynamics with 857 
Flex-EM (65), and normal mode analysis with iMODFIT (66) similar to a previous 858 
study (67). Flexible fitting was performed using secondary structure elements (SSEs) 859 
as rigid bodies (and loop regions treated as “all-atoms”), and the local cross-860 
correlation of SSEs were calculated using the SCCC scoring function in TEMPy. The 861 
SCCC scores for Flex-EM and iMODFIT models were compared. To capture the 862 
results of both fitting methods, the best fitting SSEs from iMODFIT were combined 863 
with the Flex-EM models. Finally, using Flex-EM, an all atom refinement was 864 
performed on loops that connected iMODFIT and Flex-EM SSEs. Global cross-865 
correlation analysis showed an increase in score after fitting, and QMEAN analysis 866 
showed no degradation in model quality (Table 2). In addition, SMOC scores show 867 
an increase in local cross-correlation (Figure 2-figure supplement43). For the ADP, 868 
NN, and AMPPNP states, there remained several loops with low local cross-869 
correlation scores (7-20 % below the mean score). These loops had clear 870 
corresponding density, but which was also ambiguous. To represent this, 500-1000 871 
loop conformers were calculated as above. Following clustering based on cross-872 
correlation and C RMSD, five conformers from the top cluster were selected.  873 
 874 
Finally, tubulin (PDB ID: 1JFF (68)) was rigidly fit into the EM densities. The 875 
interaction interface between MKLP2-MD and tubulin was calculated via docking 876 
driven by HADDOCK (69, 70). 50 non-interfacial MKLP2-tubulin residue pairs were 877 
selected at random, then the C-C distances were calculated and used as 878 
unambiguous distance restraints to preserve the MKLP2-tubulin rigid fit. Phi/psi 879 
angles were also restrained. In addition, density corresponding to loop6 was 880 
calculated by generating synthetic density of each MKLP-MD motor core model (i.e. 881 
modelled elements apart from loop6) and subtracting it from the relevant 882 
experimental density. 883 
 884 
 885 
 886 
  887 
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FIGURE LEGENDS 888 
 889 
Figure 1. Atypical biochemistry of MKLP2 motor domain. A) Domain 890 
organisation of MKLP2 and Kif5b (Kin1). Residues at domain boundaries are shown; 891 
the construct characterised in this study is indicated by red numbers. The motor 892 
domains are coloured in dark blue and green for MKLP2 and Kin1, respectively, and 893 
this colour scheme is used throughout. B) MT-activated steady state ATPase velocity 894 
plotted as a function of [tubulin] for MKLP2 1-520 (grey) or 25-520 (blue).  Data were 895 
fit to a Michaelis Menten kinetic (dashed grey, solid blue curves) yielding values for 896 
kcat and K0.5,MT  shown (inset). C) Kinetics of binding of 2’ deoxy 3’ mant ATP (2’dmT) 897 
to MKLP2-MD (25-520). The fluorescence increase consists of a fast (solid circles) 898 
and slow (open circles) phase. The rate constants for the two phases for a complex 899 
of MKLP2 with MTs (blue) showed a dependence on [2’dmT] that is very similar to 900 
those in the absence of MTs (grey). In both the presence/absence of MTs, the rate 901 
constant for the faster phase varied linearly with [2’dmT], defining apparent second 902 
order rate constants and y intercepts that are very similar to each other. D) Kinetics 903 
of binding of 2’ deoxy mant ADP (2’dmD) to MKLP2-MD (25-520). As in panel C, 904 
nucleotide free MKLP2 (grey) and nucleotide free MKLP2:MT (blue) were mixed with 905 
2’dmD. E) MT binding affinities of MKLP2-MD with different nucleotides. Kds were 906 
determined by fitting to a quadratic equation. Two technical replicates for 7 data 907 
points of the NN- and ADP- states were performed. Where technical replicates were 908 
performed, the average and SEM are plotted, otherwise individual data points are 909 
shown 910 
 911 
Figure 2. MKLP2 motor domain, cryo-EM reconstructions and nucleotide-912 
dependent subdomain movements. A) The MKLP2-MD has multiple loop inserts 913 
compared to Kin1. The Kin1 MD-ADP.AlFx structure (PDB: 4HNA) is shown on the 914 
left. Our MKLP2-MD-ADP.AlFx model is shown on the right, with its specific loop 915 
inserts coloured and labelled in pink. The 25-520 construct contains 31 extra 916 
residues at its N-terminus compared to Kin1, while its C-terminus ends at an 917 
equivalent length. B) The asymmetric unit of the MKLP2-MD-ADP.AlFx MT-bound 918 
cryo-EM reconstruction (grey transparent density) with docked MKLP2-MD model in 919 
blue, α-tubulin model in light grey and β-tubulin model in dark grey. MKLP2-MD and 920 
tubulin secondary structure elements at the interface are labelled. C and D) 921 
Subdomain rearrangements in Kin1 crystal structures (C) and MKLP2-MD (D) viewed 922 
towards the MT plus end. Subdomains for kinesin-1 and MKLP2-MD are assigned 923 
and coloured based on Cao et al (29). C) Kinesin-1: left, ADP (PDB: 1BG2); middle, 924 
NN + tubulin (PDB: 4LNU); right ADP.AlFx + tubulin (PDB: 4HNA). D) The MKLP2-925 
MD models are shown within cryo-EM density also coloured by subdomain. For each 926 
nucleotide-dependent transition, subdomain rotations for the P-loop and SwitchI/II 927 
subdomains are shown in degrees relative to the tubulin binding subdomain, which 928 
remains static in all states.  Subdomain movements between Kin1 ADP and NN 929 
states (indicated in light text) are not directly comparable to their MKLP2-MD 930 
counterparts, because the Kin1-ADP structure is not tubulin-bound and has an 931 
atypical tubulin-binding subdomain conformation. 932 
 933 
Figure 3. Conservation and divergence at the MKLP2-MD nucleotide binding 934 
pocket. View of the MKLP2-MD nucleotide binding pocket showing nucleotide-935 
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dependent transitions in helix-α4, P-loop (brown), loop9 (yellow) and loop11 (red). In 936 
the ADP state (left), density corresponding to ADP is visible and connected to the P-937 
loop, while in the NN state (middle), density for nucleotide is no longer present 938 
(arrowhead). In the ADP.AlFx state, a hydrolysis-competent ‘closed’ nucleotide 939 
pocket conformation is observed, loop11 becomes fully ordered with a single helical 940 
turn contacting α–tubulin H3’ (arrow), and loop9 forms an ordered β-hairpin which 941 
contacts the nucleotide (arrowhead). 942 
 943 
Figure 4. MKLP2-specific loop insertions at the MT interface and global tilt and 944 
shift of MKLP2-MD on the MT surface. A) Loop12 insertion (pink) partially 945 
contributes to the C-terminal extension of helix-α4 (extra length indicated by arrows) 946 
but does not contact the MT. This extension is present in all nucleotide states; shown 947 
here for MKLP2-MD-ADP.AlFx. B) In MKLP2-MD-ADP.AlFx the loop8 insertion (pink) 948 
reaches across to β-tubulin in the adjacent protofilament (pf, demarcated by a red 949 
dashed line). Tubulin density <7Å away from the insertion is coloured in pink. C) In 950 
MKLP2-MD-ADP.AlFx the loop2 insertion (pink) reaches towards the MT minus end 951 
contacting α-tubulin. Tubulin density <7Å away from the insertion is coloured in pink. 952 
D) Overlay of asymmetric unit MKLP2-MD-ADP.AlFx MT-bound model (blue pipes 953 
and planks) and Kin1 (green pipes and planks) MT-bound model (16) when the 954 
tubulin dimers are superimposed. The density and model of tubulin in the MKLP2-955 
MD-ADP.AlFx model is shown (transparent grey density). When their tubulins are 956 
aligned, a global shift (orange arrow indicates shift direction) and rotation (on the axis 957 
shown in red) of the MKLP2-MD on the MT surface is observed compared to Kin1. 958 
E) This relative shift and rotation moves MKLP2-MD’s (blue model) loop7 closer to β-959 
tubulin. F) MKLP2-MD Loop11 is further from α-tubulin H12 and closer to H3 in 960 
comparison to Kin1 (green transparent model). Density for MKLP2-MD-ADP.AlFx-MT 961 
(grey mesh). 962 
 963 
Figure 5. MKLP2 has an altered footprint on the MT surface. The binding 964 
interface of A) MKLP2-MD-ADP.AlFx compared to B) Kin1-MD-ADP.AlFx. i) The 965 
binding surface of MKLP2-MD and Kin1 coloured according to the electrostatic 966 
potential. ii) The binding surface of MKLP2-MD and Kin1 coloured according to α- or 967 
β-tubulin contacts. iii) MT footprint of MKLP2-MD (top) compared to Kin1 (bottom). 968 
Coloured labels and dashed lines indicate contacting secondary structure elements 969 
in each motor. Tubulin density <7Å distance from the bound motors is coloured. In 970 
MKLP2-MD-ADP.AlFx, loop2 is ordered and contacts α-tubulin (pink density) while 971 
the ordered loop8 contacts the neighbouring tubulin asymmetric unit (pink asterisk).  972 
 973 
Figure 6. MKLP2 neck-linker response to nucleotide. A) MKLP2-MD-ADP has a 974 
short helix-α6 leaving a gap between its terminus and helix-α4 (arrow), showing the 975 
cleft for the neck linker is closed and the CNB is not formed. Helix-α6 has relatively 976 
poor density, suggesting it may be partially disordered at its C-terminus (arrowhead). 977 
Density that could flexibly accommodate part of the neck linker is present connected 978 
to β-sheet1 (blue dotted line). B) MKLP2-MD-NN also has a short helix-α6 leaving a 979 
gap between its terminus and helix-α4 (arrow). C) MKLP2-MD-ADP.AlFx has an 980 
extended helix-α6, the initial portion of the neck-linker (magenta) inserts between the 981 
N-terminus (orange) and helix-α4 forming the CNB (arrowhead). The remaining 982 
portion of the neck-linker is flexible. D) Sequence alignments of representative 983 
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members (in brackets) of the Kin1/3/4/5/6 families for the neck-linker and its contact 984 
regions. Residue colouring using the Clustal X scheme (71). Sequence numberings 985 
for Kif5b (Kin1, green) and MKLP2 (kinesin-6, blue) are shown adjacent to the 986 
secondary structure schematics. Well conserved residues in MKLP2 are boxed in 987 
light blue, whereas otherwise well conserved residues which have diverged in 988 
MKLP2 are boxed in black (see also Figure 6-figure supplement2). Asterisks indicate 989 
conserved hydrophobic residues participating in CNB formation. Regions of the neck-990 
linker involved in CNB formation or core docking are indicated by dashed lines in 991 
orange and magenta, respectively. E) Time-resolved fluorescence anisotropy of 992 
FlAsH labeled MKLP2-MD: 1) NN +MT, light blue; 2) ADP.AlFx –MT, grey and 3) 993 
ADP.AlFx +MT, dark blue. Data shown in the table below are representative of 5 994 
replicate samples. F) MKLP2-MD-ADP.AlFx neck-linker in magenta (disordered 995 
region, dashed line). Kin1 helix-α6 and neck-linker (dark green) has been 996 
superimposed on helix-α6 of MKLP2-MD, showing the expected position of the neck-997 
linker. There is no density corresponding to a docked neck-linker (arrows) suggesting 998 
it is mainly disordered. A small amount of density close to helix-α5 (arrowhead) likely 999 
indicates that alternative conformations are flexibly explored. 1000 
 1001 
Figure 7. Visualisation of MKLP2’s loop6 insertion. A,B) MKLP2-MD-ADP.AlFx 1002 
model (dark blue) within the cryo-EM density (grey) with ordered loop6 density (pink). 1003 
A model of the predicted α-helix at the loop6 N-terminus fits well into a ‘sausage’ of 1004 
loop6 density (pink helix). The termini of loop6 in the model are indicated 1005 
(arrowheads). B) View from the MT proximal side of the MKLP2-MD. Loop6 density 1006 
(pink) connects the core β-sheet and β5a/b of the tubulin-binding subdomain 1007 
(asterisk). C) Movement of loop6 in NN (medium blue) to ADPAlFx (navy blue) 1008 
transition, with the loop6 helices shown as white or pink ribbons respectively. The 1009 
MKLP2-MD-ADP.AlFx motor core density is shown as transparent grey solid, 1010 
MKLP2-MD-ADP.AlFx loop6 density is shown as pink transparent solid and MKLP2-1011 
MD-NN loop6 density is shown as pink mesh. D) View of ~4 asymmetric units with 1012 
the MT plus end towards the top of the panel. Mesh shows density for the MKLP2-1013 
MD-ADP.AlFx reconstruction when low pass filtered to ~15Å. The MKLP2-MD-1014 
ADP.AlFx model is docked in one asymmetric unit. After low pass filtering, additional 1015 
less ordered density attributable to loop6 was observed to the top left of the motor 1016 
domain (indicated within pink dashed ring). Ordered loop6 density as in the previous 1017 
panels is shown in pink (and arrowhead). 1018 
 1019 
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FIGURE SUPPLEMENT LEGENDS 1022 
 1023 
Figure 1 – Figure supplement 1. The rate of ADP release from MKLP2-MD in the 1024 
absence of MTs is unusually high. Fluorescence transient for the release of 2’ 1025 
deoxy mant ADP (2’dmD) from MKLP2-MD in the presence of high concentrations of 1026 
unlabelled ADP in the absence of MTs. The data are plotted in blue with the fit to a 1027 
single exponential decay shown in yellow. The inset depicts a similar experiment on 1028 
a 20-fold longer time scale, demonstrating that larger, slower kinetic components are 1029 
not present in these data. 1030 
 1031 
Figure 2 – Figure supplement 1. Evaluation of the resolutions and nucleotide 1032 
occupancy of the MKLP2-MD-MT reconstructions. A-D) Overall resolutions of 1033 
each reconstruction were estimated from 0.143 criteria of the FSCtrue curves 1034 
calculated according to the gold-standard noise-substitution method (72); A) MKLP2-1035 
MD-ADP-MT, B) MKLP2-MD-NN-MT, C) MKLP2-MD-ADP.AlFx-MT D) MKLP2-MD-1036 
AMPPNP-MT. E-H) Local resolutions in the asymmetric unit of each reconstruction 1037 
were estimated using the blocres program implemented in Bsoft (73), and are 1038 
depicted as slices through the reconstruction with the comparative models docked. 1039 
These show generally higher resolutions for tubulin and regions of the MKLP2-MD 1040 
proximal to tubulin; E) MKLP2-MD-ADP-MT, F) MKLP2-MD-NN-MT, G) MKLP2-MD-1041 
ADP.AlFx-MT, H) MKLP2-MD-AMPPNP-MT. Each reconstruction is coloured using 1042 
the most individually informative color range. I-L) Zoomed in view of the nucleotide 1043 
pocket in I) MKLP2-MD-ADP, J) MKLP2-MD-NN, K) MKLP2-MD-ADP.AlFx, L) 1044 
MKLP2-MD-AMPPNP reconstructions. Density, represented as mesh, <8Å away 1045 
from the model’s nucleotide is shown and density <5Å away is coloured in green. In 1046 
the case of the MKLP2-MD-NN, the ADP of the MKLP2-MD-ADP model is shown as 1047 
translucent sticks after the two models were superimposed, reflecting the absence of 1048 
density for nucleotide in the MKLP2-MD-NN reconstruction consistent with our 1049 
sample preparation procedures.  1050 
 1051 
Figure2 - Figure supplement 2. High-resolution tubulin density features. 1052 
Cryo-EM density for the central region of α-tubulin in the MKLP2-MD ADP.AlFx 1053 
reconstruction after a B-factor of -200 is applied to 4.2Å to reflect local resolution 1054 
estimates (as shown in Figure 2 - Figure supplement 1). Beta-strand separation and 1055 
helical pitch are resolved, consistent with a resolution in this region of <4.5Å. 1056 
 1057 
Figure 2 – Figure supplement 32. A protocol describing the different stages for 1058 
creating atomic models of MKLP2-MD. The first step was a data preparation 1059 
stage, involving generation and selection of MKLP2-MD homology models (described 1060 
in detail in methods), and appropriate segmentation of the maps to avoid model 1061 
biases. Second, a pre-flexible fitting refinement stage was used to identify poor fitting 1062 
loops using local cross-correlation calculations (Fig2 – figure supplement 43), and to 1063 
generate and select better fitting loops. In the third stage, flexible fitting was 1064 
performed in a hybrid manner, combining results from Flex-EM and iMODFIT as 1065 
guided by local cross-correlation calculations for secondary structure elements. 1066 
Finally, docking was used to predict the MKLP2-MD-tubulin interface, and multiple 1067 
loop conformations were calculated to represent regions of ambiguous density. 1068 
 1069 
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Figure 2 – Figure supplement 43. Local Fitting Improves at Each Model 1070 
Refinement Stage. Local cross-correlation scores were calculated for A) MKLP2-1071 
MD-ADP B) MKLP2-MD-NN C) MKLP2-MD-ADP.AlFx D) MKLP2-MD-AMPPNP 1072 
models using SMOC scoring in TEMPy. SMOC scores were sequentially calculated 1073 
for homology models (light grey), loop refined models (dark grey), and the final 1074 
flexibly fitted models (blue) to represent progression in model fitting. Exemplar SCCC 1075 
scores for flexible fits of SSEs in MKLP2 as shown in cut-away views of the E) 1076 
MKLP2-MD-ADP, F) MKLP2-MD-NN, G) MKLP-MD-ADP.AlFx, H) MKLP2-MD-1077 
AMPPNP reconstructions, with density in mesh and the corresponding fitted models 1078 
colored according to normalised SCCC score as a measure of local fit quality for 1079 
individual secondary structural elements. Secondary structural elements with poor 1080 
density at density at conservative thresholds, such as loop12 shown for the AMPPNP 1081 
model, are represented where possible with clusters of multiple solutions to reflect 1082 
the uncertainty in their conformational modelling or are removed where this is not 1083 
possible.   1084 
 1085 
Figure 3 – Figure supplement 1. Comparison of MKLP2 nucleotide binding site 1086 
with other N-kinesins. A) Sequence alignment of important regions at the 1087 
nucleotide pocket for kinesin-6 MKLP2 and representative members from other 1088 
Kin1/3/4/5 for which X-ray structures are available. Residue letters are coloured 1089 
according to their properties according to the Clustal X scheme (71). Information on 1090 
consensus, conservation and secondary structure is shown above the alignments. 1091 
Sequence numberings for Kif5B (Kin1, green) and MKLP2 (kinesin-6, blue) are 1092 
shown adjacent to the secondary structure schematics. Highly conserved/similar 1093 
kinesin residues are boxed in light blue, whereas highly conserved kinesin residues 1094 
which have diverged are boxed in black.  The signature kinesin switch I and II 1095 
sequences are indicated. B) The nucleotide pocket of the X-ray structure of tubulin-1096 
bound Kin1 in the presence of ADP.AlFx (PDB 4HNA, (26)). The position of the 1097 
switch I/II sequences are annotated in cyan, whilst those that have diverged in 1098 
MKLP2 are shown in sticks and annotated in black, in format Kin1 amino-acid, Kin1 1099 
amino-acid number, mouse MKLP2 amino-acid. C-E) The nucleotide binding regions 1100 
in the NN states of C) kinesin-6 MKLP2, D) Kin1 Kif5a and E) Kin3 Kif1A (16) are 1101 
shown in their corresponding experimental densities (grey density for MKLP2-MD, 1102 
green densities for Kin1 and Kin3). Arrows indicate full extension of helix-α4’s N-1103 
terminus in this state and arrowheads indicate formation of a single-turn helix in 1104 
loop11 for Kin3 and Kin1 that contacts the MT, in contrast to MKLP2 where these 1105 
regions are less ordered. 1106 
 1107 
Figure 3 – Figure supplement 2. Conservation of nucleotide-dependent 1108 
subdomain movements and location and configuration of the clefts that 1109 
separate them in Kin1 and MKLP2. A) The NC and PC in Kin1 ADP (PDB: 1BG2), 1110 
NN (PDB: 4LNU) and ADP.AlFx crystal structures (PDB: 4HNA). With ADP, the NC 1111 
is closed (loop11 contacts the P-loop) while the PC is open (loop11 does not contact 1112 
helix-α4). In the NN state, the NC opens (loop11 releases its contact with the P-loop 1113 
and instead associates with helix-α4) and the PC closes. In the ADP.AlFx state the 1114 
PC remains closed and the NC closes as loop11 contacts both the P-loop and helix-1115 
α4. The position of N255, which reorientates upon nucleotide release to contact 1116 
loop11 and close the polymer cleft is shown (17). B) MKLP2 follows the same state-1117 
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dependent sequence of changes at the NC and PC clefts as Kin1. MKLP2-MD cryo-1118 
EM density is shown in transparent grey with the same views shown as for Kin1 in 1119 
panel A. The predicted position of N430 (corresponding to kinesin-1’s N255) in the 1120 
models is indicated. 1121 
 1122 
Figure 3 – Figure supplement 3. MT-bound MKLP2-MD-AMPPNP does not 1123 
adopt an “ATP-like state”. A) Side profile of the asymmetric unit of the MKLP2-MD-1124 
AMPPNP reconstruction, showing MT binding site similar to that seen in other 1125 
nucleotide states. The fitted MKLP2-MD-AMPPNP model is in blue, the α-tubulin 1126 
model is in light grey and the β-tubulin model is in dark grey. B) View, similar to Fig 1127 
3C, of the nucleotide-binding site of the MKLP2-MD-AMPPNP reconstruction.  1128 
 1129 
Figure 4 – Figure supplement 1. MKLP2 specific inserts are nucleotide 1130 
sensitive. Views of A) loop12, B) loop8 and C) loop2 as in Fig 4A, B and C 1131 
respectively for the MKLP-MD-ADP reconstruction. Views of D) loop12, E) loop8 and 1132 
F) loop2 as in Fig 4A,B and C respectively for the MKLP-MD-NN reconstruction. 1133 
Loop12 density was not clear in the ADP and NN states at the thresholds used in Fig 1134 
4A for the MKLP2-MD-ADP.AlFx reconstruction, suggesting higher flexibility; 1135 
although there was some density at less conservative thresholds (not shown) 1136 
allowing modelling of conformers. Densities for loop8 and loop2 in the ADP and NN 1137 
states were absent except at much less conservative thresholds and therefore were 1138 
not modelled.  1139 
 1140 
Figure 4 – Figure supplement 2. MKLP2 has an altered binding orientation on 1141 
the MT surface in all nucleotide states. A) Overlay of asymmetric unit MKLP2-MD-1142 
NN MT-bound model (blue pipes and planks) and kinesin-1 (green pipes and planks) 1143 
MT-bound model (16) when the tubulin dimers are superimposed. The density and 1144 
model of tubulin in the MKLP2-MD-NN model is shown (transparent grey density). 1145 
When their tubulins are aligned, a global shift (orange arrow indicates shift direction) 1146 
and rotation (on the axis shown in red) of the MKLP2-MD on the MT surface is 1147 
observed with respect to Kin1.  1148 
 1149 
Figure 5 – Figure supplement 1. MKLP2 has an altered footprint on the MT 1150 
surface in all nucleotide states. The MT binding surface of A) MKLP2-MD-ADP, B) 1151 
MKLP-MD-NN compared to C) Kin1-NN. Secondary structure elements at the 1152 
binding interface are annotated. A single tubulin dimer is shown where black labels 1153 
indicate tubulin secondary structure elements on α-tubulin (light grey model) and β-1154 
tubulin (dark grey model). Colored labels and dashed lines indicate respective 1155 
contacting secondary structure elements of MKLP2-MD or kinesin-1. Tubulin density 1156 
<7Å distance from the bound motors is coloured.  1157 
 1158 
Figure 6 – Figure supplement 1. The neck-linker in MT-bound MKLP2-MD-1159 
AMPPNP is not directed towards the MT plus end. A) View, similar to Fig 6A-C, of 1160 
the N-terminus, helix-α6 and neck-linker of the MKLP2-MD-AMPPNP reconstruction. 1161 
The arrow indicates a gap between helix-α6 and helix-α4, suggesting a shortened 1162 
helix-α6, a closed docking cleft and therefore no CNB formation or neck-linker 1163 
docking. The fitted MKLP2-MD-AMPPNP model is in blue and the α-tubulin model is 1164 
in light grey.  1165 
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 1166 
Figure 6 – Figure supplement 2. MKLP2’s neck-linker has an atypical sequence 1167 
across species that precludes core-docking. A) Sequence alignment of the 1168 
mouse MKLP2 neck-linker sequence with the two other mouse kinesin-6s MKLP1 1169 
and MPP1 and MKLP2 from selected animal species. Species abbreviations are; 1170 
Mm, Mus musculus, Hs, Homo sapiens, Gg, Gallus gallus, Xl, Xenopus laevis, Dr, 1171 
Danio rerio. Residue letters are coloured according to their properties according to 1172 
the Clustal X scheme (71). Information on consensus, conservation and secondary 1173 
structure is shown above the alignments. Sequence numberings for Kif5B (Kin1, 1174 
green) and mouse MKLP2 (kinesin-6, blue) are shown adjacent to the secondary 1175 
structure schematics. Highly conserved residues in plus end kinesins which remain 1176 
conserved or have similar properties in kinesin-6s are boxed in light blue, whereas 1177 
highly conserved kinesin residues which have diverged are boxed in black (see also 1178 
Fig 6D). Conserved hydrophobic residues participating in forming the CNB are 1179 
marked by asterisks. Regions of the neck-linker involved in CNB formation or core-1180 
docking are indicated by dashed lines in orange and magenta, respectively. B) The 1181 
cover-neck bundle (CNB) and docked-neck linker in the x-ray structure of tubulin-1182 
bound Kin1 Kif5b (PDB: 4HNA). Side chains are shown for conserved kinesin 1183 
residues involved in CNB formation (region within the orange-dashed circle) and 1184 
neck-linker docking (region within the magenta-dashed circle). Highly conserved 1185 
residues that remain conserved or highly similar are annotated in cyan, whilst those 1186 
that have diverged are annotated in black, in format Kin1 amino-acid, Kin1 amino-1187 
acid number, mouse MKLP2 amino-acid. C) Full neck-linker docking is observed in 1188 
all structures with an ATP analogue and a ‘closed’ hydrolysis-competent nucleotide 1189 
pocket apart from kinesin-6 MKLP2; Kin1 Kif5b (PDB: 4HNA, (26)), Kin3 Kif1a (PDB: 1190 
4UXR, (16)), Kin4 Kif4 (PDB: 3ZFD, (33)), Kin5 Kif11 (PDB: 3HQD, (34)). For 1191 
MKLP2, a dashed magenta line is used to represent neck-linker flexibility. 1192 
 1193 
Figure 7 – Figure supplement 1. Density visualised for MKLP2’s loop6 is not 1194 
dependent on nucleotide state. Views of loop6 density for the A) MKLP2-MD-ADP 1195 
or B) MKLP2-MD-NN (as in Fig 7A), and C) MKLP2-MD-ADP or the D) MKLP2-MD-1196 
NN reconstructions (as in figure 7B). The MKLP2-MD atomic models are shown 1197 
within cryo-EM density (blue for NN or light blue for ADP). A model of the predicted 1198 
α-helix at the loop6 N-terminus fits well into a ‘sausage’ of loop6 density (pink helix). 1199 
The termini of loop6 in the model are indicated (arrowheads). Loop6 density (pink) 1200 
connects the core β-sheet and β5a/b of the tubulin-binding subdomain (asterisk). E) 1201 
Sequence alignment of loop6 in MKLP2 from various animal species and the 1202 
chanoflagellate Monosiga brevcollis. Species abbreviations are; Mm, Mus musculus, 1203 
Hs, Homo sapiens, Xl, Xenopus laevis, Pb, Python bivittatus, Ss, Salmo Salar, Hv, 1204 
Hydra Vulgaris, Gg, Gallus gallus, Cg, Crassostrea gigas, Mb, Monosiga brevcollis, 1205 
Bi, Bombus impatiens, Dm, Drosophila melanogaster. Residue letters are coloured 1206 
according to their properties as in Clustal X scheme (71). Information on consensus, 1207 
conservation and secondary structure, including prediction of SSEs in loop6 (see 1208 
Methods) is shown above the alignments. Sequence numberings for Kif5b (Kin1, 1209 
green) and mouse MKLP2 (kinesin-6, blue) are shown adjacent to the secondary 1210 
structure schematics. 1211 
 1212 
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Movie 1. Subdomains within MKLP2-MD-ADP.AlFx cryo-EM reconstruction. The 1214 
organisation of kinesin subdomains is illustrated within the MKLP2-MD-ADP.AlFx 1215 
model, with cryo-EM density shown as colored mesh and the model as colored 1216 
ribbon (Switch I/II subdomain, blue, P-loop subdomain, orange, Tubulin-binding 1217 
subdomain magenta, α-tubulin, light grey and β-tubulin, dark grey). ADP.AlFx 1218 
nucleotide is shown as yellow ball-and-stick representation; nucleotides and 1219 
paclitaxel have been removed from the tubulin model for clarity. Also for clarity, 1220 
density mesh for loop6 is not colored. A clipping plane is moved though the MD to 1221 
show the boundaries of the subdomains, the model is rotated, and the cryo-EM 1222 
density and the tubulin model are removed for a clearer view of the tubulin-binding 1223 
subdomain. Finally, the colour scheme is changed to that used in the majority of 1224 
figures; the MKLP2-MD-ADP.AlFx model is in navy blue except for the colored key 1225 
structural elements. 1226 
 1227 
Movie 2. Changes at the nucleotide-binding site during the MKLP2-MD ATPase 1228 
cycle. Nucleotide-state transitions are represented by morphing cryo-EM density 1229 
between MKLP2-MD-ADP and MKLP2-MD-NN reconstructions then MKLP2-MD-NN 1230 
and MKLP2-MD-ADP.AlFx reconstructions using Chimera’s (63) ‘Morph Map’ tool 1231 
(with the option of adjusting threshold for a constant volume). The MKLP2-MD-ADP 1232 
fitted model is shown first and substituted for the MKLP2-MD-NN fitted model 1233 
halfway through the ADP to NN density morph. The MKLP2-MD-NN fitted model is 1234 
then substituted for the MKLP2-MD-ADP.AlFx fitted model halfway through the ADP 1235 
to NN density morph. 1236 
 1237 
Movie 3. Loop6 density in the MKLP2-MD-ADP.AlFx cryo-EM reconstruction. 1238 
Cryo-EM density for the MD core and tubulin are shown in transparent grey solid, 1239 
whilst additional density attributable to loop6 is shown as transparent pink solid. An 1240 
α-helix at the N-terminus of loop6, suggested by secondary structure prediction (see 1241 
Methods and Fig7-figure supplement1E), which when modelled (pink helix) fits well 1242 
into a ‘sausage’ of density attributable to a portion of loop6, is introduced. All density 1243 
apart from loop6 density is then removed for clarity. 1244 
  1245 
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Table 1. Kinetic and affinity data of monomeric Kinesin-1, -3, and -5 compared 1246 
to MKLP2-MD. A summary of steady state ATPase activities and MT affinities of 1247 
monomeric Kin1 (16,19-21,23,24-26), whose structures were used to compared with 1248 
MKLP2, as well as Kin3 (25). Kin5’s MT-stimulated ATPase activity has similar 1249 
values as MKLP2 (22,27).   1250 
 1251 
Monomeric 
motor 
MT-stimulated ATPase MT affinity; Kd (M) 
K0.5, MT (M) kcat (S
-1
) ADP NN ADP.AlFx AMPPNP 
MKLP2-MD 1.07±0.18 4.38±0.20 0.363±0.057 0.043±0.002 0.355±0.073 0.043±0.035 
Kin1 
(Kif5a/b) 
12.7±4.0 (16) 
26.0±5.8 (24) 
34.2±5.7 (16) 
43.6±7.8 (24) 
50.3±1.6 (26) 
20.8±2.4 
(24) 
2.0±0.3 (26) 
n.a. 
1.4±0.2 (24) 
0.3±0.006 (26) 
1.1±0.1 (24) 
0.045±0.012 
(26) 
Kin3 (Kif1a) 0.0537±0.005
7 (16) 
43.4±1.0 (16) 
0.0068±0.00
25 (25) 
n.a. 
0.0059±0.001
5 (25) 
0.0042±0.001
3 (25) 
Kin5 
(Eg5) 
4.5 (22) 
0.29±0.02 (27) 
2.9 (22) 
5.5±0.1 (27) 
n.a. n.a. n.a. n.a. 
n.a.: not available 1252 
 1253 
 1254 
 1255 
 1256 
 1257 
 1258 
 1259 
 1260 
 1261 
 1262 
 1263 
 1264 
 1265 
 1266 
 1267 
 1268 
 1269 
 1270 
 1271 
 1272 
 1273 
 1274 
 1275 
1276 
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 1277 
Table 2: MKLP2 Homology modelling and validation. Columns 2-3 show the list 1278 
of PDB IDs that were used as templates for specific structural regions of each 1279 
MKLP2 nucleotide state (4LNU (29), 4HNA (26), 4OZQ (74), 1VFV (25), 3GBJ and 1280 
4Y05 are structures from the Structural Genomics Consortium). Columns 4-5 show 1281 
the overall QMEAN scores calculated before, and after refinement and show that 1282 
model quality is maintained following refinement. Columns 6-7 show the global cross-1283 
correlation scores before and after refinement. 1284 
  1285 
Nucleotide 
State 
Templates Used for 
Homology Modelling 
QMEAN Scores 
Global Cross-
correlation Scores 
MKLP2 
Structure 
Template 
Homology 
Model 
Refined 
Model 
Homology 
Model 
Refined 
Model 
ADP 
Main template 3GBJ 
0.636 0.623 0.908 0.931 
Helix 4, helix 
5, loop 8 
4LNU 
Helix 4/loop 
12 
4OZQ 
Loop 2 4Y05 
NN 
Main template 4LNU 
0.669 0.663 0.913 0.930 
Helix 4/loop 
12 
4OZQ 
Loop 2 4Y05 
Loop 5 3GBJ 
ADP.AlFx 
Main template 4HNA 
0.671 0.689 0.860 0.890 
Helix 4/loop 
12 
4OZQ 
Loop 2 4Y05 
Loop 5 3GBJ 
AMPPNP 
Main template 1VFV 
0.658 0.679 0.925 0.943 
Helix 4, helix 
5, loop 8 
4LNU 
Helix 4/loop 
12 
4OZQ 
Loop 2 4Y05 
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